Healthcare Providers

 
 
 

A CALL-TO-ACTION REMAINS

The National Colorectal Cancer Roundtable set forth an ambitious goal in 2014: to screen 80% of eligible Americans by 2018. Unfortunately, two years into the initiative only a 0.9% increase was achieved. A December 2018 American Journal of Gastroenterology article reviewed 58 studies on reasons patients did not follow through on colon screening. They reported fears of sedation, suffering complications, embarrassment and anticipated pain from the colonoscopy. But the number one concern was
…(you guessed it) the prep!

 
 

THE PREP HURDLE

The most common, repetitive, prep-related complaints we hear as physicians involve bad taste, unintended sided effects such as bloating, nausea, and vomiting, and the extremely restricted diet.

 
 

GROWING BODY OF EVIDENCE

A meta-analysis of nine studies comparing low-residue and clear liquid diets in preparation for colonoscopy showed that patients better tolerate a low-residue diet and are more willing to repeat the preparation. The analysis did not show a difference in the quality of bowel prep between the two approaches. Gastrointest Endosc 2016;83:499-507.

 
 

THE SOLUTION

Colon preps are either prescription or OTC laxatives depending on physician and patient preferences. We published an observational study using a standardized low residue food kit and off label laxatives in a novel dosing schedule to minimize unintended side effects. Patient tolerance and prep completion were high with 98% adequate prep (BBPS >6) with average BBPS of 8. Cecal intubation was achieved in all patients except for patients with strictures, obstructing CRC and one poor prep. Patients at high risk for poor prep were NOT EXCLUDED.

 
doctor-patient-BG.jpg

 With 12,000 (and counting) procedures performed, there’s a reason patients tell their friends and family to
use Happy Colon Foods.

HC_pattern-02.jpg
 

Benefits

Happier Patients

Alleviate patients’ complaints of hunger, bad taste, and side effects

Decrease calls about problems with prep

Fewer no-shows and cancellations due to inability to complete prep

 
 

Successful Procedures

COMPLIANCE: Increase compliance with initial screening and surveillance exams

COMPLETION: Remove the “difficult” from difficult to prep patients; increase overall prep completion rates

PREVENTION: Increase screening rates to prevent CRC and save lives. The North American CRC screening rate for adults ages 50-74 is only 55%-58%.

QUALITY: Excellent real-world ADR’s and cecal intubation rates.

 

Increased Patient Volume

Primary Care physician referrals

Patient referrals via word of mouth

 
provider-benefits-2.jpg
FACT
CRC is the most commonly diagnosed and most common cause of cancer death in men younger
than 50.§

As a healthcare provider,
How Do I Get Started?

 
 

OTC LAXATIVE

Our Original kit comes bundled with PEG 3350 and 25mg Senna tablets. Call us at
(855) 423-6637 to obtain a provider code.

Give patients your code and direct them to visit our site or call to order their kit.

Custom instruction sheets and order pads
are also available to make the
process seamless for clinical staff.


PRESCRIPTION LAXATIVE

Patients using a prescription laxative, can enjoy the low-residue foods in our kit while they prep.

Call us at (855) 423-6637 to obtain your provider code, which patients will use to order their food only kits.

Custom instruction sheets and order pads are also available to make the process seamless for clinical staff.

 
 

HAPPY COLON FOODS kits are shipped via UPS and arrive within 2-5 business days.

FACT
CRC in those younger than 50 accounts for 11% of all male cases and 10% of all
female cases.
 
 

*Centers for Disease Control & prevention. Behavioral Risk Factor Surveillance Survey. https://www.cdc.gov/brfss/index.html. Accessed 9 Sept., 2018.

†Singh H, Bernstein CN, Samadder JN, Ahmed R. Screening rates for colorectal cancer in Canada: a cross-sectional study. CMAJ Open. 2015;3:E149-157.

‡Wolf AMD, Fontham ETCH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68:250-81.

§Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017; 67:177-92.

‖Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal cancer incidence patterns in the United States, 1974-2013. J Natl. Cancer Inst. 2017;109.